NCT05769855View on ClinicalTrials.gov

A Study of HR18034 for Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy

PHASE3CompletedINTERVENTIONAL
Enrollment

294

Participants

Timeline

Start Date

March 21, 2023

Primary Completion Date

October 30, 2023

Study Completion Date

October 30, 2023

Conditions
Postsurgical Pain Management
Interventions
DRUG

HR18034

HR18034 380mg

DRUG

ropivacaine HCl

ropivacaine HCl 75mg.

DRUG

Sodium Chloride Physiological Solution

Sodium Chloride Physiological Solution 20ml

Trial Locations (1)

410000

The Third Xiangya Hospital of Central South University, Changsha

All Listed Sponsors
lead

Shanghai Hengrui Pharmaceutical Co., Ltd.

INDUSTRY